CI
NBIX icon

Cowen Inc’s Neurocrine Biosciences NBIX Stock Holding History

Cowen Inc’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-41,100
Closed -$1.89M – 277
2017
Q2 		$1.89M Buy
+41,100
New +$1.99M 0.1% 120
2017
Q1 		– Sell
-12,500
Closed -$484K – 283
2016
Q4 		$484K Buy
+12,500
New +$566K 0.02% 192
2015
Q3 		– Sell
-35,000
Closed -$167K – 380
2015
Q2 		$167K Buy
35,000
+16,700
+91% +$708K 0.01% 388
2015
Q1 		$1K Buy
+18,300
New +$655K ﹤0.01% 390
2014
Q1 		– Sell
-10,000
Closed -$93K – 223
2013
Q4 		$93K Hold
10,000
– – 0.02% 203
2013
Q3 		$113K Buy
+10,000
New +$137K 0.02% 189

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return